The sequential gross margin expansion from 29.6% in 2026Q1 to 44.9% in 2026Q2 suggests that fixed-cost absorption is finally materializing as revenue scales, but the sustainability hinges on maintaining utilization above breakeven. Operating margin of 21.9% in 2026Q2 marks the first positive quarter in the series, yet the prior ten quarters averaged deeply negative margins, implying that the current profitability is cyclical rather than structural. Investors should monitor whether gross margin can hold above 30% as product mix shifts and capacity expansion costs ramp.

The inventory days on hand of 324 days in 2026Q2, though down from 408 days in 2026Q1, remains exceptionally high and suggests either deliberate stockpiling of raw materials or potential obsolescence risk in GaAs. DSO improved to 66 days from 98 days sequentially, reflecting better collection discipline, but the overall CCC of 336 days is far above the peer average, indicating that working capital efficiency is a structural drag. The negative working capital swing of -$16.3M in 2026Q2, per cash flow statement, underscores that revenue growth is consuming cash, which may pressure liquidity if the demand inflection falters.

The dramatic deleveraging is primarily a function of the equity raise rather than debt reduction, with total debt actually rising to $85.4M. Interest coverage is not calculable for 2026Q2, but prior quarters showed deeply negative coverage, indicating that debt service was previously a strain; the new cash position likely alleviates near-term refinancing risk. However, the forward EV/EBITDA of 558x suggests the market is pricing in a massive EBITDA recovery, and any shortfall could re-lever the balance sheet if debt is used to fund the 6-inch InP expansion.

The quick ratio of 4.00 in 2026Q2 indicates that even excluding inventory, current assets comfortably cover current liabilities, a stark contrast to the 0.85 quick ratio in 2025Q3 when liquidity was strained. This fortress-like position appears to be externally funded via the capital raise, not organic generation, as retained earnings remain negative at -$55.4M. The ample liquidity provides a multi-year runway to fund capacity expansion and weather potential demand volatility, but investors should note that the cash is largely unproven in generating returns, given the low ROA of 1.4%.

The improvement from -2.8% ROIC in 2025Q1 to +1.6% in 2026Q2 is a positive inflection, but the absolute level remains far below the company's likely weighted average cost of capital, implying value destruction on a risk-adjusted basis. The surge in equity from the capital raise has temporarily depressed ROE to 1.7%, as the new capital has not yet been deployed into productive assets. The key driver of future returns will be whether the 6-inch InP capacity expansion can generate incremental margins that lift ROIC sustainably above 10%, which appears uncertain given the historical volatility.